Original Research
Published on 25 Feb 2019
Safety and Therapeutic Profile of a GnRH-Based Vaccine Candidate Directed to Prostate Cancer. A 10-Year Follow-Up of Patients Vaccinated With Heberprovac
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2019.00049
- 6,997 views
- 11 citations
